major depressive disorder Clinical Trials and Research
Also known as: depression, clinical depression, unipolar depression, major depression, depressive illness, mdd · ICD-10: F32-F33
Major depressive disorder (MDD) is a common mood disorder characterized by persistent sadness, loss of interest, and other symptoms that interfere with daily life. Clinical trial research focuses on developing new treatments, understanding its causes, and improving existing therapies. Find a Trial helps patients search for active studies.
Search major depressive disorder trials →
Common questions about major depressive disorder clinical trials
Who can participate in clinical trials for major depressive disorder?
Eligibility criteria vary by study, often including age, diagnosis confirmation, and specific symptom severity. Researchers use these criteria to ensure patient safety and collect relevant data. Information is available on ClinicalTrials.gov.
What are the different phases of clinical trials for depression?
Clinical trials progress through phases (1, 2, 3, 4) to test new treatments. Early phases assess safety and dosage, while later phases evaluate effectiveness and compare new options to existing ones. Data is publicly available on ClinicalTrials.gov.
Do clinical trials for major depressive disorder cost money?
Often, study-related medical care and interventions are provided at no cost to participants. However, other expenses like travel or lost wages are typically not covered. Patients should clarify financial details with the research team.
What new treatments are being studied for major depressive disorder?
Researchers are exploring novel medications, brain stimulation techniques, and different forms of psychotherapy. Studies also investigate personalized approaches based on genetic or biological markers. This research is often supported by NIH RePORTER and listed on ClinicalTrials.gov.
What types of interventions are typically tested in MDD clinical trials?
Trials commonly evaluate new antidepressant medications, psychotherapy methods like CBT, and neuromodulation techniques such as transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT). Some studies also explore lifestyle interventions or digital therapeutics.
Are there specific biomarkers being investigated in MDD research?
Yes, researchers are studying genetic markers, neuroimaging findings, and blood-based biomarkers to better understand MDD and predict treatment response. Identifying these could lead to more targeted therapies. Information on such studies can be found on NIH RePORTER.
What are common reasons someone might not be eligible for an MDD trial?
Common exclusion criteria include co-occurring severe mental health conditions, certain medical illnesses, substance use disorders, or current use of specific medications. These help ensure participant safety and study focus. Specifics vary by trial on ClinicalTrials.gov.
What is it like to participate in a clinical trial for depression?
Participation often involves regular visits, assessments of mood and symptoms, and potentially taking a study medication or undergoing a specific therapy. Participants are closely monitored by a research team throughout the study. Details are provided in the informed consent process.
How to find a major depressive disorder trial that fits you
- Describe your major depressive disorder situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all major depressive disorder trials →